Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Founder David Schwartz Dies at 88

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories' Founder David Schwartz died on Sunday, the company announced. He was 88.

Schwartz was the president, CEO, and, chairman of the firm from 1957 until 2003 when his son, Norman Schwartz, succeeded him. He remained chairman of the company's board from 1957 until his passing.

Schwartz and his wife, Alice Schwartz, founded Bio-Rad in 1952 in Berkeley, Calif. after both graduated from the University of California, Berkeley. Originally, the firm developed and produced chemicals used in biochemical, pharmaceutical, and other life science research applications, and expanded into the clinical diagnostics field in the 1960s when it developed its first test kit for thyroid function based on separation methods and materials developed for life science research.

Today, Bio-Rad, headquartered in Hercules, Calif., has about 7,000 employees. In 2011 it posted $2.07 billion in revenues.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.